We describe an early prenatal diagnosis and the successful treatment of fet
al Graves' disease from transplacental transfer of maternal thyroid stimula
ting autoantibodies (TSAb), The diagnosis of fetal thyrotoxicosis was made
by umbilical cord sampling (UBS) at 20 weeks gestation, based on suppressed
TSH with elevated FT4 levels. Therapy with propylthiouracil (PTU) improved
fetal thyroid function tests as well as the clinical signs of fetal Graves
' disease. Three more UBS were conducted before delivery indicating persist
ing mild fetal hyperthyroidism.
Undetectable concentrations of thyrotrophin in fetal serum in the presence
of markedly elevated FT4, suggests pituitary negative feedback at as early
as 20 weeks gestation.
Amniotic fluid thyrotrophin levels were measured at 20,24 and 26 weeks and
were shown to correlate better with (elevated) maternal rather than (suppre
ssed) fetal TSH values; therefore, we believe that amniotic fluid thyrotrop
hin measurement is unreliable for prediction of fetal thyroid status,
Our observation is the first documentation of an intact feedback mechanism
so early in fetal development and it suggests that pituitary maturation occ
urs earlier than previously believed.